| Barbara Anne Commins, RN | |
|
1600 Holloway Ave, Student Health Services San Francisco State University, San Francisco, CA 94132-4200 | |
| (415) 338-1351 | |
| (415) 338-6834 |
| Full Name | Barbara Anne Commins |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1600 Holloway Ave, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003875121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 207421 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Anne Commins, RN 1600 Holloway Ave, Student Health Services San Francisco State University, San Francisco, CA 94132-4200 Ph: (415) 338-1351 | Barbara Anne Commins, RN 1600 Holloway Ave, Student Health Services San Francisco State University, San Francisco, CA 94132-4200 Ph: (415) 338-1351 |
News Archive
Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that in general had better clinical outcomes with oral controllers than inhaled corticosteroids.
Regentis Biomaterials announced today new clinical data demonstrating the efficacy and safety of its GelrinC implant for treating articular cartilage in injured knees. As presented at the International Cartilage Repair Society World Congress in Izmir, Turkey, the clinical results demonstrated sustained knee function improvement over 24 months after implantation and significant pain reduction.
Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today presented detailed results from two double-blind Phase 2 studies, each designed to evaluate the safety and effectiveness of ATX-101, a first-in-class injectable drug for the reduction of small volumes of fat.
Protein Potential LLC has received support from the National Institute of Allergy and Infectious Diseases of the NIH in the form of a Phase II Small Business Innovation Research Grant. The three-year award totaling approximately $3 million will support translational research to develop a vaccine for the prevention of malaria caused by the parasite Plasmodium vivax.
› Verified 9 days ago
Rocio C Agraz-lara, RN, PHN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 Potrero Ave, Zsfg Building 90 4th Floor, San Francisco, CA 94110 Phone: 415-206-8524 Fax: 415-206-6545 | |
Ms. Cecile A O'connor, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 52 Dore St, San Francisco, CA 94103 Phone: 415-861-0828 Fax: 415-861-0140 | |
Mr. Gregory Sumner Payne Brynelson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 555 Mission Rock St Unit 103, San Francisco, CA 94158 Phone: 415-513-2902 | |
Elisabeth Leslie Goldstein, RN, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1171 Mission St, San Francisco, CA 94103 Phone: 415-734-4231 Fax: 415-734-4218 | |
Michalle Ramirez-mclaughlin, RN, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1545 Divisadero St, San Francisco, CA 94143 Phone: 415-353-7900 | |
Gemma Rose Cohen, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 721 Baker St, San Francisco, CA 94115 Phone: 641-919-7259 | |
Araceli Sanchez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-476-1000 |